Arctic Therapeutics Secures €26.5 Million in Series A Funding to Advance Dementia Treatments Arctic Therapeutics just closed a €26.5 million Series A financing to enhance anti-amyloid treatments for dementia and skin diseases.

Arctic Therapeutics Secures €26.5 Million in Series A Funding to Advance Dementia Treatments #Iceland #Reykjavik #Arctic_Therapeutics #Sanos_Group #Investment_Funding

Arctic Therapeutics Secures €26.5M Investment to Advance Groundbreaking Treatments for Dementia Icelandic company Arctic Therapeutics has closed a €26.5 million Series A financing to enhance dementia and skin disease treatments, attracting significant investors.

Arctic Therapeutics Secures €26.5M Investment to Advance Groundbreaking Treatments for Dementia #Iceland #Reykjavik #Arctic_Therapeutics #Sanos_Group #EIC_Fund